{
    "nct_id": "NCT03176849",
    "official_title": "A Randomized Phase IV Control Trial of Single High Dose Oral Vitamin D3 (Stoss Therapy) in Pediatric Patients Undergoing HSCT to Prevent Vitamin D Deficiency and Insufficiency During Transplant",
    "inclusion_criteria": "* All pediatric patients, ages 1 to 25 years of age, undergoing hematopoietic stem cell transplant at Phoenix Children's hospital\n* Patients must sign an informed consent\nHealthy volunteers allowed\nMust have minimum age of 1 Year\nMust have maximum age of 25 Years",
    "exclusion_criteria": "* Prior rejection of hematopoietic stem cell transplant",
    "miscellaneous_criteria": ""
}